Author: OurCrowd

Newsletter: Improving cancer treatment + My vaccine shot

Startup of the week: OncoHost cancer care Me, Joe and a spoonful of sugar OurCrowd teams up with BNZ for New Zealand clients Join me live: Israel and the UAE in 2021 Superpedestrian raises $60M for smart e-scooters Signals Analytics snapped up by Kenshoo Arbe’s radar revolution to fuel safer cars Morphisec: shape-shifting software that outwits hackers Freightos integrates ‘Freight-as-a-service’ into websites Startup of the week: OncoHost cancer careNobel Prize winner Prof. Aaron Ciechanover has hailed the breakthrough in cancer immunotherapy developed by OurCrowd portfolio company OncoHost and joined their scientific advisory board. “Until now, cancer treatment has been what I call one size fits all. We bombarded the patient with chemotherapy, radiotherapy, with enormous side effects,” Ciechanover said. “Now we are narrowing it. We are going to be much more precise. We are going to provide treatment that has much less side effects. And we may discover new pathways that are involved in carcinogenesis, enabling us to develop new drugs. They can really profile the patients into groups of patients that will respond to the treatment and those that...

Read More